Last Price
0.024
Today's Change
0.00 (0.00%)
Day's Change
0.023 - 0.024
Trading Volume
1,090,065
Market Cap
12 Million
Shares Outstanding
533 Million
Avg Volume
3,006,928
Avg Price (50 Days)
0.03
Avg Price (200 Days)
0.02
PE Ratio
-2.40
EPS
-0.01
Earnings Announcement
27-Feb-2024
Previous Close
0.02
Open
0.02
Day's Range
0.023 - 0.024
Year Range
0.017 - 0.048
Trading Volume
1,090,065
1 Day Change
0.00%
5 Day Change
-4.00%
1 Month Change
-14.29%
3 Month Change
4.35%
6 Month Change
33.33%
Ytd Change
-4.00%
1 Year Change
0.00%
3 Year Change
-81.54%
5 Year Change
-86.55%
10 Year Change
-91.11%
Max Change
-91.11%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, which is in Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. It has collaborative partnerships with GE Healthcare to discover i-bodies that bind to granzyme B; and Carina Biotech Pty Ltd. to develop CAR-T cell products against various solid tumor antigens. AdAlta Limited was incorporated in 2006 and is headquartered in Bundoora, Australia.